Amgen bone drug for use in cancer patients
More than 50 percent of cancer patients experience complications when cancer spreads to their bones, according to the company.
Doctors will administer Xgeva to patients in once-a-month injections. The drug works by blocking a protein that breaks down bone cells.
No comments:
Post a Comment